Cephalosporins, carbapenems, and monobactams

Infectious Disease Clinics of North America

Volumn 14, Issue 2, 2000, Pages 435-447

  Asbel, Lenore E ^b   Levison, Matthew E ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; CARBAPENEM DERIVATIVE; CEFACLOR; CEFADROXIL; CEFALEXIN; CEFAMANDOLE; CEFAZOLIN; CEFEPIME; CEFIXIME; CEFONICID; CEFOPERAZONE; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFPODOXIME; CEFPROZIL; CEFTAZIDIME; CEFTIBUTEN; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CILASTATIN PLUS IMIPENEM; LORACARBEF; MEROPENEM; MONOBACTAM DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; DRUG CLASSIFICATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG URINE LEVEL; HUMAN; NONHUMAN; REVIEW; TREATMENT INDICATION;

EID: 0034027093     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70256-7     Document Type: Article

References (36)

1. J. Acar Rapid emergence of resistance to cefepime during treatment Clin Infect Dis 26 1998 1484 1486
2. P.S. Barie S.B. Vogel E.P. Dellinger A randomized double blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime intra-abdominal infection study group Arch Surg 132 1997 1294 1302
3. J.G. Bartlett R.F. Breiman L.A. Mandell Community-acquired pneumonia in adults: Guidelines for management Clin Infect Dis 26 1998 811 838
4. A. Basoli E.Z. Meli P. Mazzocchi Imipenem/cilastatin (1.5 g daily) versus meropenem (3.0 g daily) in patients with intra-abdominal infections: Results of a prospective, randomized multicentre trial Scand J Infect Dis 29 1997 503 508
5. Center for Disease Control and Prevention 1998 guidelines for treatment of sexually transmitted diseases MMWR Jan 23, 1998
6. W.A. Craig The pharmacology of meropenem, a new carbapenem antibiotic Clin Infect Dis 24 suppl 2 1997 s266 s275
7. B.A. Cunha M.V. Gill Cefepime Med Clin North Am 79 1995 721 732
8. B.A. Cunha Meropenem in elderly and renally impaired patients Int J Antimicrob Agents 10 1998 107 117
9. R.J. Dattwyler J.J. Halperin D.J. Volkman Treatment of late Lyme borreliosis— randomized comparison of ceftriaxone and penicillin Lancet 1 1988 1191
10. E.P. Dellinger P.A. Gross T.L. Barrett Quality standard for antimicrobial prophylaxis in surgery Clin Infect Dis 18 1994 422 427
11. J. Duval C.J. Soussy J.F. Acar In-vitro antibacterial activity of cefepime: A multicentre study J Antimicrob Chemother 32 suppl B 1993 55
12. P. Eggiman M.P. Glauser M. Aoun Cefepime monotherapy for the empirical treatment of fever in granulocytopenic cancer patients J Antimicrob Chemother 32 suppl B 1993 151
13. L.O. Gentry G. Rodriguez-Gomez Randomized comparison of cefepime and ceftazidime for treatment of skin, surgical wound and complicated urinary tract infections in hospitalized subjects Antimicrob Agents Chemother 35 1991 2371 2374
14. H. Giamarellou Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions Am J Med 80 6B 1986 126 137
15. S. Harbarth D. Pittet V. Gabriel Cefepime—assessment of its need at a tertiary care center J Clin Pharm Therapeutics 23 1998 11 17
16. J.S. Kahan F.M. Kahan R. Goegelman Thienamycin: Development of imipenem-cilastatin J Antimicrob Chemother 12 suppl D 1983 1
17. G.L. Kearns R.A. Young Ceftibuten pharmacokinetics and pharmacodynamics. Focus on pediatric use Clin Pharmacokinet 26 1994 169 189
18. M. Kilpatrick Aztreonam for treating meningitis caused by gram-negative rods Scand J Infect Dis 1991
19. P. Leophante A. Bertrand G. Nouvet A comparative study of cefepime and ceftazidime in the treatment of community-acquired lower respiratory tract infections J Antimicrob Chemother 32 1993 165
20. B.S. Margaret G.L. Drusano H.C. Standiford Emergence of resistance to carbapenenem antibiotics in Pseudomonas aeruginosa J Antimicrob Chemother 24 supplement A 1989 161
21. A. Martelli V. Cortecchia L. Ventrigllia Aztreonam in the treatment of urinary tract infections: A multicenter trial Chemotherapy 35 suppl 1 1989 8 14
22. Y.S. Moon K.C. Chung M.A. Gill Pharmacokinetics of meropenem in animals, healthy volunteers, and patients Clin Infect Dis 24 suppl 2 1997 S249 S255
23. S.R. Norrby Carbapenems Med Clin North Am 79 1995 745 759
24. S. Oster H. Edelstein K. Cassano Open trial of cefepime (BMY 28142) for infections in hospitalized patients Antimicrob Agents Chemother 34 1990 954
25. Owens R.C. Jr C.H. Nightingale D.P. Nicolau Ceftibuten: An overview Pharmacotherapy 17 1997 707 720
26. A. Pikis J.A. Donkersloot S. Akram Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae J Antimicrob Chemother 40 1997 108 105
27. Raad II E.E. Whimbey K.V. Rolston A comparison of aztreonam plus vancomycin and impenem plus vancomycin as initial therapy for febrile neutropenic cancer patients Cancer 77 1996 1386 1394
28. K.V. Rolston P. Berkey G.P. Bodey A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients Arch Intern Med 152 1992 283 291
29. S.C. Sanyal E.M. Mokaddas The increase in carbapenem use and emergence of Stenotrophomonas maltophilia as an important nosocomial pathogen J Chemother 11 1999 28 33
30. R. Sharifi R. Gecker S. Childs Treatment of urinary tract infections: Selecting an appropriate broad-spectrum antibiotic for nosocomial infections Am J Med 100 1996 76S 82S
31. B. Stamboulian P. Bonveni C. Arevalo Antibiotic management of outpatients with endocarditis due to penicillin-susceptible streptococci Rev Infect Dis 13 Suppl 2 1991 160 163
32. E.A. Swabb Clinical pharmacology of aztreonam in healthy recipients and patients: A review Rev Infect Dis 7 4 1988 5605 5612
33. R.B. Sykes D.P. Bonner Aztreonam: The first monobactam Am J Med 78 1985 2 10
34. A.R. Tunkel W.B. Scheld Acute meningitis Mandell G.L. Douglas J.E. Dolin R. Principles and Practice of Infectious Diseases ed 4 1995 Churchill Livingstone New York 831
35. R. Williams D. Hotchkin Aztreonam plus clindamycin versus tobramycin plus clindamycin in the treatment of intraabdominal infections Rev Infect Dis 13 suppl 7 1991 s629 s633
36. W.R. Wilson A.W. Karchmer A.S. Dajani Antibiotic treatment of adults with infective endocarditis due to Streptococci, Enterococci, Staphylococci, and HACEK Microorganisms JAMA 274 1995 1706 1713